Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02369770 · ClinicalTrials.gov registry record · NA

Sensory-Motor Rehabilitation Post Stroke

A NA study of Acute Stroke, sponsored by University of Maryland, Baltimore.

Recruiting
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT02369770: Recruiting NA study of Acute Stroke, sponsored by University of Maryland, Baltimore.

NCT02369770 is a NA study of Acute Stroke that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 140 participants, below the 6,112-participant average among 10 other Acute Stroke trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02369770, a NA study of Acute Stroke, is actively recruiting participants, sponsored by University of Maryland, Baltimore.

RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

Early after stroke, patients often have significant motor impairment and sensory deficit. Evidence has demonstrated heightened plasticity and significant recovery in the acute phase (first months) post stroke but there has been a lack of effective and practical protocols and devices for early intensive sensorimotor therapy.This research study will conduct a randomized clinical trial of an intensive motor-sensory rehabilitation on patients with acute stroke using a wearable rehabilitation robot. The primary aims are to facilitate sensorimotor recovery, reduce ankle impairments, and improve balance and gait functions. This clinical trial will be conducted on the Study and Control groups of acute stroke survivors.

Primary Outcome

The assessment is a measure of lower extremity (LE) motor and sensory impairments.

Conditions Studied

Interventions

  • DEVICE stretching and active movement training

Study Locations (1)

Maryland

  • University of Maryland, Baltimore - Baltimore

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2019-04-26
Est. Completion 2026-12-31
Phase NA
University of Maryland, Baltimore

560 total trials

What NCT02369770 shows while recruiting

NCT02369770 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 6,112-participant average among 10 other Acute Stroke trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Acute Stroke appearing as the primary indexed condition, and to 1 intervention - of which stretching and active movement training is the first listed.

NCT02369770 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT02369770 about?

NCT02369770 is a clinical study titled "Sensory-Motor Rehabilitation Post Stroke". Early after stroke, patients often have significant motor impairment and sensory deficit. Evidence has demonstrated heightened plasticity and significant recovery in the acute phase (first months) post stroke but there has been a lack of effective and practical protocols and devices for early intens...

What is the current status of trial NCT02369770?

This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2019-04-26. Estimated completion is 2026-12-31.

What conditions does trial NCT02369770 study?

This clinical trial studies the following conditions: Acute Stroke.

What interventions are being tested in trial NCT02369770?

The interventions under investigation include: stretching and active movement training (DEVICE).

Who is sponsoring clinical trial NCT02369770?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02369770 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02369770's enrollment target sits among peer trials

140 3rd of 10 higher than 8 of 10 other Acute Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Acute Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

  • NCT02507141 · 140 participants

    Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02369770, the US trial registry maintained by the National Library of Medicine. NCT02369770 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.